Category Biology/Biotechnology

Switched-on DNA: Sparking Nano-Electronic Applications

EC gate control of DNA conductance. (a) Illustration of the experiment, where the source and drain electrodes are the STM tip and substrate, and EC gate is a silver electrode inserted in the solution. A DNA molecule bridged between the source and drain electrodes via the thiolate linker groups, where charge hops from one base to the next (red arrows) via overlapping π-orbitals. The source-drain bias (Vds), and the EC gate voltage (Vg) are controlled independently. (b) From left to right: redox modified DNA (Aq-DNA), where a base was replaced with an anthraquinone (Aq) moiety (highlighted in blue) at the 3′-end of a DNA strand (see chemical structure in Supplementary Fig. 1a); three-dimensional structure (PDB ID: 2KK5, results are from nuclear magnetic resonance study17) shows that the Aq moiety intercalated in between the two Guanine bases on the other strand acts as a hopping site (red arrows) with its π-orbital overlapping with those from adjacent bases. Aq moiety is shown in blue. Picture is created from 2KK5 in PDB with JSmol software. DNA without the Aq moiety (u-DNA) was studied as control. Both Aq-DNA and u-DNA contain a strand terminated with thiolated linkers at the 3′- and 5′-ends for contact with the source and drain electrodes.

EC gate control of DNA conductance.

DNA may very well also pack quite the jolt for engineers trying to advance the development of tiny, low-cost electronic devices. Much like flipping your light switch at home – only on a scale 1,000 times smaller than a human hair – an ASU-led team has developed the first controllable DNA switch to regulate the flow of electricity within a single, atomic-sized molecule.

“It has been established that charge transport is possible in DNA, but for a useful device, one wants to be able to turn the charge transport on and off. We achieved this goal by chemically modifying DNA,” said Tao, who directs the Biodesign Center for Bioelectronics and Biosensors and is a professor in the Fulton Schools of Engineering...

Read More

Prospect for more Effective Treatment of Nerve Pain

 A novel substance inhibits the pain effectively and is well tolerated. (Picture: Center of Dental Medicine; UZH)

A novel substance inhibits the pain effectively and is well tolerated. (Picture: Center of Dental Medicine; UZH)

Trigeminal neuralgia is characterized by sharp, lancinating pain in the teeth or facial area. The standard treatment for this chronic nerve pain can cause burdening side effects. A novel substance inhibits the pain effectively and is well tolerated, as documented by the initial results of an international study involving the Center of Dental Medicine at the University of Zurich.

Trigeminal neuralgia pain bouts are triggered by touch, such as shaving, putting on make-up, showering, talking and tooth brushing, or even a gust of wind...

Read More

Yeast found in Babies’ Guts increases Risk of Asthma

Pichia fungus

The fungus Pichia, a type of yeast, is linked to kids’ likelihood of developing asthma, new research shows.

University of British Columbia microbiologists have found a yeast in the gut of new babies in Ecuador that appears to be a strong predictor that they will develop asthma in childhood. The new research furthers our understanding of the role microscopic organisms play in our overall health. “Children with this type of yeast called Pichia were much more at risk of asthma,” said Brett Finlay, a microbiologist at UBC. “This is the first time anyone has shown any kind of association between yeast and asthma.”

In previous research, Finlay and his colleagues identified 4 gut bacteria in Canadian children that, if present in the first 100 days of life, seem to prevent asthma...

Read More

Discovery of Genetic ‘Switch’ could help to Prevent Symptoms of Parkinson’s disease

 dATF4 regulation of mitochondrial folate-mediated one-carbon metabolism is neuroprotective. Cell Death and Differentiation, 2017; DOI: 10.1038/cdd.2016.158

dATF4 regulation of mitochondrial folate-mediated one-carbon metabolism is neuroprotective. Cell Death and Differentiation, 2017; DOI: 10.1038/cdd.2016.158

A genetic ‘switch’ has been discovered by MRC researchers at the University of Leicester which could help to prevent or delay the symptoms of Parkinson’s disease. The team discovered that a gene called ATF4 plays a key role in Parkinson’s disease, acting as a ‘switch’ for genes that control mitochondrial metabolism for neuron health. Dr Miguel Martins from the MRC Toxicology Unit at the University of Leicester explained: “When the expression of ATF4 is reduced in flies, expression of these mitochondrial genes drops. This drop results in dramatic locomotor defects, decreased lifespan, and dysfunctional mitochondria in the brain.”

“Intere...

Read More